Misses Wall Streets Expectation AGAIN Q3 LOSS

Q3 Yes you guessed it Heron Misses Wall Streets Expectation AGAIN
a loss of $48.5 million in its third quarter.

The Redwood City, California-based company said it had a loss of $1.24 per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

Heron Therapeutics shares have decreased 40 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $16.10, a fall of 43 percent in the last 12 months.

 

uh oh someone's carried interest is diminishing

 

cool story bro